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Introduction
Liver transplantation (LTX) is a routine and effective
treatment for patients with end stage liver disease caused
by virus infection, alcoholic liver disease, etc. [1]. One of
the serious complications is arterial stenosis or thrombo-
sis, which is associated with a high risk of liver graft dys-
function. The rate of hepatic artery thrombosis (HAT)
and stenosis (HAS), is 2–12% in liver transplant patients
[2, 3]. In a recent study, Vivarelli et al. [4] analyzed the
predisposing factors retrospectively. Besides surgical tech-
nical failures, donor age and back table arterial recon-
struction caused frequently early HAT. Cerebrovascular
cause of donor death and use of an iliac conduit were in-
dependent risk factors in cases of late HAT. HAS devel-
oped more frequently after retransplantation and Cy-
tomegalo Virus (CMV) infection. HAT and HAS might
be fatal in the early postoperative period [5, 6], requiring
urgent treatment: the most invasive approach is repeated
transplantation, with difficulties due to shortage of donor
organs. Early surgical revascularization is a widely used
option with the disadvantage of operative stress to the
patients. The reported survival rate is inferior in both
groups compared to the population without hepatic ar-
tery complications, or primarily chosen iliac conduit re-
construction [7–9]. Minimally invasive techniques have
been widely used in pre- and post-transplantation [10]
management, including endovascular management in the
treatment of hepatic artery complications for years. Per-
cutaneous transluminal balloon angioplasty (PTA), stent
or stent-graft placement, thrombus aspiration and fibri-
nolysis are reported to be a tolerable therapeutic choice
producing good results [11–15].
The aim of this retrospective study was to analyze our
follow-up data of early arterial complications treated by
surgical or interventional methods focusing on hepatic
artery patency, biliary complication, patient survival and
especially on graft loss (avoiding the need for retrans-
plantation).
Methods
Patients: The clinical data of patients are presented in
Table I. 365 patients after cadaver or living donor liver
transplantation was examined and retrospectively
searched as part of our single center transplantation pro-
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gram. In this retrospective study, we report on all 25 (7%)
liver transplant recipients who developed early (within 30
days) hepatic artery complication after transplantation.
In these patients 17 HAT, 13 HAS were diagnosed; four
patients had HAS with a subsequent HAT. Hepatic ar-
tery complication was treated by PTA/stenting and fib-
rinolysis procedures in 10 patients (Interventional
Group), and by surgical revascularization/retransplanta-
tion in 15 patients (Surgery Group).
Intraoperative and postoperative imaging: Since 2003,
intraoperative Color Doppler Ultrasound (IOP CDUS)
[16] has been performed at the end of liver transplanta-
tion by one of the radiologists. Bedside Color Doppler
Ultrasound (CDUS) examination was performed to
monitor adequate liver perfusion in every case postoper-
atively being aware of the fact, that the changes of
Doppler signal in an artery precede the abnormal labora-
tory values [17]. Postoperative CDUS was performed in
every 24–48 hours during the first week by one of the ra-
diologists. The CDUS diagnosis of arterial complication
was based on the following criteria: pulse-wave Doppler
imaging signs (peak systolic velocity>2 m/sec); absence
of intraparenchymal arterial signal; “parvus tardus” in-
traparenchymal arterial signal (systolic velocity<30
cm/s; resistive index (RI)<0.5; acceleration time>0.1
s) or direct visualization of the lesion [18, 19].
If the suspicion of arterial complication emerged,
Computed Tomography Angiography (CTA) with 3-Di-
mensional (3D) reconstruction (Figs 1–2) and/or
Catheter-angiography (DSA) was performed. In the In-
terventional group, 4 patients had CTA and 6 had DSA
after the CDUS examination. In the Surgery group, 3 pa-
tients were treated after the diagnosis of CDUS alone;
CTA was performed in 8 and DSA in 5 cases. In both
groups, DSA was performed in equivocal cases after
CDUS, or, when initially endovascular therapy was
planned.
Interventional radiology technique: For percutaneous
therapy in one case brachial and in seven cases femoral ap-
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Table I Demographic data of patients with early arterial complica-
tions
Age (in years) Recipients Donors
Mean (St.dev.) 41.28 (10.77) 38.57 (10.94)
Gender Nr %
Female 10 40
Male 15 60
Indications for LTX Nr %
Acut 1 4
ALD 5 20
Autoimmune 3 12
Cryptogenic 1 4
HCV 7 28
HCV/ALD 2 8
HCV/HCC 3 12
PSC 2 8
Adenomatosis 1 4
Types of complications Nr %
HAS 8 32
HAT 12 48
HAT+HAS 5 20
Abbreviations: ALD: alcoholic liver disease, HAS: hepatic artery stenosis, HAT:
hepatic artery thrombosis, HCC: hepatocellular carcinoma, HCV: cirrhosis re-
lated to Hepatitis C virus infection, LTX: liver transplantation, PSC: primery scle-
rotising cholangitis
Fig. 1. CTA volume rendered reconstruction shows complete oc-
clusion of the hepatic artery (arrow) in a 42-year-old liver
transplant recipient 7 days after transplantation
Fig. 2. Sagittal CTA maximum intensity projection reconstruction
shows patent infrarenal conduit (arrows) in a 52-year-old
liver transplant recipient 28 days after transplantation
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proach were used, with Seldinger technique. After selec-
tive catheterization of the common hepatic artery, multi-
ple projection digital angiographies were performed. The
length of the stenosis was measured carefully, and after
crossing the stenosis, an appropriate sized balloon catheter
and/or stent was chosen. All PTA was performed with
0.018” systems (Johnson and Johnson Medical, Bel-
gium), or percutaneous transluminal coronary angioplasty
(PTCA) balloons (Abbot Vascular Devices, Medlines,
Hungary). Palmaz stent (Johnson and Johnson Medical,
Belgium) of 4 mm diameter on a 0.018” delivery system
and a coronary stent (Boston Scientific, Hungary) of 3.5
mm diameter were applied. In the third case a self-ex-
pandable nitinol stent 8 mm in diameter, 60 mm in length
(Johnson and Johnson, Cordis, Hungary) was implanted
into the iliac conduit. For control and backup 6F guiding
catheters or 5F long sheathes (Johnson and Johnson
Medical, Belgium) were used. For fibrinolysis, recombi-
nant tissue plasminogen activator (rTPA) (Boehringer In-
gelheim GmbH, Germany) was used in a dose of 13–30
Fig. 3a. CDUS (left panel) and DSA (right panel) imaging in a 23-year-old liver transplant recipient with hepatic artery stenosis before inter-
vention. CDUS examination shows resistance index of 0.33 in the poststenotic hepatic artery. DSA shows a short anastomotic steno-
sis on the hepatic artery
Fig. 3b. CDUS (left panel) and DSA (right panel) imaging in the same patient after intervention. Control CDUS shows improved arterial flow
with a resistance index of 0.60. Control DSA shows patent hepatic artery after stent placement
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mg. During the treatments, additional intra-arterial he-
parin (5000 IU) was administered. In 10 patients 14 in-
terventions were performed; 6 PTA alone, 3 primary stent
implantations and 5 fibrinolysis (Fig. 3a–b).
Surgical therapy: The liver transplant surgeons per-
formed the surgical management of the arterial compli-
cations. The applied techniques were surgical thrombec-
tomy with revision of the anastomosis (9 cases), grafting
with an iliac artery segment from the donor (4 cases) and
retransplantation (2 cases). In 15 patients, 15 surgical
procedures were performed to re-establish arterial flow,
or liver function.
Results
The results of the different treatments are shown in Table II.
Interventional radiology group: Two of 10 patients
died, thus 5 of 8 alive are free of symptoms. One death
occurred after recanalization due to septic complication.
One patient died after a failed intervention resulting re-
transplantation for untreatable biliary strictures. In addi-
tion, 3 patients developed ischemic biliary complications;
both treated successfully by percutaneous drainage, di-
latation or metallic stent placement. Six of 8 patients had
patent hepatic artery during follow-up, one hepatic ar-
tery reoccluded 4 months after successful initial treat-
ment, without clinical signs, remained untreated. There
was only one procedure related complication: after fibri-
nolysis a subhepatic hematoma developed, requiring sur-
gical evacuation 3 days later.
Surgery group: 10 of the 15 patients are alive (1 had re-
transplantation, 5 had early surgical reanastomosis and 4
had iliac artery conduit interposition). Three of 15 pa-
tients developed biliary complications (in 2 patients after
surgical revision); one of these patients was treated with
percutaneous intervention, and one patient with retrans-
plantation. In addition, one more patient had retrans-
plantation. 9 hepatic arteries remained patent during fol-
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Table II Clinical data of the treated patients
Interventional group (Days)
Type of
complications
Primary
treatment
Start
of therapy
Follow-up Results HA patent Liver failure / ReTx Exit
1 HAS PTA 1 1051 no symptoms yes no no
2 HAS STENT 7 603 BC/ReTx no yes no
3 HAS PTA 1 91 no symptoms yes no no
4 HAS PTA 3 998 no symptoms yes no no
5 HAT+HAS PTA+LY 17 25 sepsis/exit yes no yes
6 HAS PTA 2 529 treated BC yes no no
7 HAT+HAS STENT+LY 24 315 treated BC no no no
8 HAT+HAS PTA+LY 2 435 no symptoms yes no no
9 HAT PTA+LY 3 464 no symptoms yes no no
10 HAT+HAS STENT+LY 2 270 treated BC yes no no
Surgery group (Days)
11 HAT revision 2 1063 treated BC yes no no
12 HAT revision 7 1325 ReTX no yes no
13 HAT revision 1 24 sepsis/exit no no yes
14 HAT revision 1 21 sepsis/exit no no yes
15 HAT+HAS revision 1 38 BC/sepsis/exit no no yes
16 HAS revision 2 2545 no symptoms yes no no
17 HAT revision 3 296 no symptoms yes no no
18 HAS revision 5 20 no symptoms yes no no
19 HAT revision 1 48 ReTx/sepsis no yes yes
20 HAT conduit 1 926 no symptoms yes no no
21 HAT conduit 1 336 no symptoms yes no no
22 HAS ReTx 20 2968 BC yes no no
23 HAT conduit 2 221 no symptoms yes no no
24 HAT ReTx 11 12 ReTX/sepsis no yes yes
25 HAT conduit 3 744 no symptoms yes no no
Abbreviations: BC: biliary complications, conduit: iliac artery interpositum graft, HA: hepatic artery, HAS: hepatic artery stenosis, HAT: hepatic artery thrombosis,
LY: thrombolysis, PTA: percutan transluminalis ballon angioplasty, ReTx: retransplatation
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low-up. Altogether 5 patients died after surgery for arte-
rial complication, all of them due to sepsis.
In comparison, because of the arterial complication,
25% (2/8) of patients died after endovascular therapy and
33% (5/15) in the surgery group. The rate of retrans-
plantation was 10% (1/10) and 20% (3/15), and the
number of the biliary complication was 40% (4/10) and
20% (3/15), respectively. The successfully treated biliary
complications were similar in both groups. The hepatic
arteries remained patent during follow-up in 80% (Inter-
ventional Group) and in 60% (Surgery Group).
Discussion
Early diagnosis and treatment of the HAT and HAS is
recognized being mandatory to both graft and patient
survival [20–23]. HAT and HAS, especially in the early
postoperative period causes deterioration of liver func-
tion leading to liver parenchyma or biliary necrosis. Fatal
consequences require urgent retransplantation. However,
limited availability of organs and higher mortality rate
narrows this option [9, 24]. The challenge of diagnostic
radiology is to check the patency of vascular anastomoses.
The essential method is CDUS [25, 26], CTA or Mag-
netic Resonance Angiography (MRA) [27, 28]. DSA may
be needed if these techniques are unable to make a defi-
nite diagnosis and preferably as an introduction to en-
dovascular intervention [29]. Having the diagnosis of
HAT or HAS urgent surgical revascularization, revision
of anastomosis or iliac conduit interposition is required
[30]. Interventional treatment by fibrinolysis and PTA
represents a valid alternative to surgery in the manage-
ment of arterial steno-obstructive lesions after liver trans-
plantation [31–33]. Yang et al. in a recent study analyzed
their experience in 25 patients, 5 HAT and 20 HAS. Ap-
proximately half of the HAS occurred in the early post-
operative phase. Their experience with early HAT throm-
bolysis resulted in unfavorable outcome suggesting
surgical repair or retransplantation. Our experience is
somewhat different – in a multidisciplinary team ap-
proach the decision between the available treatment
methods is individual and flexible. Radiologic interven-
tion can be started and in certain points deciding further
steps consultation is advisable [34].
In the Hungarian Liver Transplant Program, the oper-
ative and interventional methods were available to treat
the complications from the beginning. The rate of arte-
rial complications decreased during our learning curve.
In this retrospective analysis early HAT and HAS cases
were included outnumbering the sporadically noticed and
usually clinically silent late arterial complications. The
monitoring of early liver vascularization and treatment of
complications is based on a protocol, containing regular
postoperative CDUS (intraoperative, at the first post-
transplantation day then every 24–48 hours during the
first week, depending on the clinical situation, then
weekly during hospitalization). In cases of diagnosed vas-
cular complications, CTA is performed whenever the
confirmation of diagnosis is required, or the acquired vol-
umetric data seems to be helpful in planning the en-
dovascular or surgical treatment. The decision between
surgical and endovascular treatment is made by a multi-
disciplinary team consisting of liver transplant surgeons,
anesthesiologists, hepatologists and interventional radi-
ologists. However, the number of patients is still low pre-
cluding detailed statistical analysis, the presented results
suggest that interventional techniques were valuable, pro-
viding good outcomes in terms of vessel patency, rate of
retransplantation and death. The development of biliary
complications was somewhat higher in this group, al-
though two of three patients were treated successfully in
both groups by means of interventional radiological tech-
niques. Having the results of this analysis our policy con-
cerning primary treatment of choice in early arterial com-
plications remains individual preferring the less invasive
interventional methods.
Abbreviations
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